Purchase Order 15B51926P00000039
Award Date 11/17/25
Potential Completion Date 11/17/25
Potential Value $1.4K
Federal Agency
Awardee
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Irving, TX 75039, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Federal Correctional Complex Pollock, a civilian facility within the Bureau of Prisons, awarded a firm fixed-price purchase order valued at $3,034.19 to McKesson Corporation on November 19, 2025, with an ultimate completion date of November 20, 2025. The contract, designated as Open Market Purchase Order 3715, contains no set-aside provisions and will be performed in Irving, Texas. McKesson Corporation, a prominent healthcare services and pharmaceutical distribution company headquartered...
- The Federal Correctional Complex Pollock awarded a $5,845.60 firm fixed price purchase order to McKesson Corporation on November 14, 2025, with an ultimate completion date of November 17, 2025. This open market purchase order carries no set-aside designation and represents a direct procurement of pharmaceutical and medical supplies for correctional facility operations. McKesson, headquartered in Irving, Texas, serves as a critical vendor for the Bureau of Prisons within the Department of...
- McKesson Corporation was awarded a $1,141.65 firm fixed price purchase order (B3-26-01 OPEN MKT PO 3704) by the Federal Correctional Complex Pollock, a civilian agency under the Department of Justice's Bureau of Prisons, with a performance location in Irving, Texas. The award was issued on September 30, 2026, with an ultimate completion date of December 5, 2025, and was conducted as an open market acquisition with no set-aside designation. This purchase order represents a routine procurement...
- McKesson Corporation was awarded a Controlled Subs Order Purchase Order (PO 3714) valued at $7,338.40 by the Federal Correctional Complex Pollock, a civilian facility under the Department of Justice's Bureau of Prisons. The firm fixed price purchase order, issued on November 14, 2025, with an ultimate completion date of November 17, 2025, represents a delivery order under McKesson's established vendor relationship with the Bureau of Prisons. The order was placed without a set-aside designation...
- The Department of Justice Bureau of Prisons Federal Correctional Complex Pollock awarded McKesson Corporation a firm fixed price purchase order valued at approximately $1,291 for pharmaceutical products. McKesson will provide the pharmaceuticals to the Bureau of Prisons facility in Irving, Texas between December 21-30, 2023. As the parent company of McKesson Drug Company, McKesson Corporation will serve as the prime contractor on this contract to supply pharmaceuticals for the Federal...
- McKesson Corporation was awarded a firm fixed price purchase order valued at $6,832.84 by the Federal Correctional Complex Pollock, a civilian facility under the Department of Justice's Bureau of Prisons. The award, designated as Controlled Subs PO 3725, was issued on December 9, 2025, with an ultimate completion date of December 10, 2025. Performance will be executed in Irving, Texas, where McKesson maintains its corporate headquarters. This contract represents a non-competed purchase order...
- The Federal Bureau of Prisons at Federal Correctional Complex Pollock awarded a firm fixed price delivery order valued at $15,282.08 to McKesson Corporation on October 22, 2025, with an ultimate completion date of January 31, 2026. This delivery order, designated REG PO 3705, was awarded without a set-aside designation and represents a continuation of McKesson's established role as a primary pharmaceutical and medical supply vendor to the Bureau of Prisons. The work will be performed in...
- McKesson Corporation has been awarded a purchase order valued at $3,660.55 for Regular Meds (PO 3711) by the Federal Correctional Complex Pollock, a civilian facility within the Department of Justice's Bureau of Prisons. This firm fixed-price contract, awarded on November 17, 2025, with an ultimate completion date of November 17, 2025, represents a routine pharmaceutical procurement to support the medical operations of the correctional facility. The purchase order will be fulfilled from...
- McKesson Corporation, a major pharmaceutical distribution and healthcare services provider headquartered in Irving, Texas, was awarded a firm fixed-price purchase order valued at $2,569.35 by the Federal Correctional Complex Pollock on July 23, 2025. The contract, which carries an ultimate completion date of August 6, 2025, covers pharmaceutical products and is classified as a non-competed award with no set-aside designation. The place of performance is Irving, Texas, where McKesson maintains...
- McKesson Corporation, a prominent healthcare services and pharmaceutical distribution company headquartered in Irving, Texas, was awarded a purchase order valued at $3,979.03 by the Federal Correctional Complex Pollock, a civilian facility under the Federal Bureau of Prisons. The contract, awarded on September 16, 2025, with an ultimate completion date of September 30, 2025, is for pharmaceutical products to support the correctional facility's healthcare operations. This firm fixed-price...